IL1B and diabetes mellitus: IL1-RA has already been described as a therapeutic candidate for diabetes mellitus II treatment, because of its protective effects: IL1-RA prevented pancreatic mononuclear cell infiltration, islet destruction and hyperglycemia in a model of induced diabetes mellitus [32].